This inventor holds 1 USPTO granted patent. Top assignees: Interthyr Research Foundation Inc., University System of Maryland. Active years: 1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1986
Title: The Innovations of William A. Valente
Introduction
William A. Valente is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of thyroid research, particularly through his innovative patent. His work has implications for understanding and treating autoimmune thyroid diseases.
Latest Patents
Valente holds a patent for a method of clinical determination and quantification of thyrotropin. This patent describes a fast-growing, continuous, functional rat thyroid cell strain known as FRTL-5. These cells maintain functional characteristics of iodide uptake and thyroglobulin synthesis over prolonged periods of culture. The FRTL-5 cells are cultured in a medium containing approximately 5 percent calf serum, supplemented with a mixture of hormones, including thyrotropin. This system allows for a series of assays that measure thyroid stimulatory or inhibitory factors, specifically evaluating patient sera, particularly those afflicted with Graves' disease and other autoimmune thyroid diseases.
Career Highlights
Throughout his career, Valente has worked with various organizations, including the Interthyr Research Foundation Inc. and the University System of Maryland. His research has contributed to advancements in the understanding of thyroid function and disease.
Collaborations
Valente has collaborated with notable individuals in his field, including Leonard D. Kohn and Paolo Vitti. These collaborations have furthered the research and development of thyroid-related assays and treatments.
Conclusion
William A. Valente's contributions to thyroid research through his innovative patent and collaborations have made a significant impact in the medical field. His work continues to influence the understanding and treatment of thyroid diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile